# Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.

> **NCT02459262** · PHASE1 · COMPLETED · sponsor: **Minervax ApS** · enrollment: 240 (actual)

## Conditions studied

- Infection by Streptococcus Group B

## Interventions

- **BIOLOGICAL:** GBS-NN vaccine

## Key facts

- **NCT ID:** NCT02459262
- **Lead sponsor:** Minervax ApS
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-04-12
- **Final completion:** 2017-04-21
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2021-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02459262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02459262, "Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02459262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*